Definition
Amastatin is a oligopeptide antibiotic complex that is a competitive inhibitor of aminopeptidases and also has antitumor property.
Discovery
Amastatin was isolated from the culture filtrate of Streptomyces spME98-M31.
Analog of Amastatin
Epiamastatin is a diastereoepimer of the effective peptidase inhibitor amastatin and differs structurally by a single transposition of the OH group with H atom at C2. Compared with amastatin, epiamastatin is pharmacologically inactive.
Structure
The structure of amastatin is (2S, 3R)-3-Amino-2-hydroxy-5-methyl-hexanoyl]-Val-Val-Asp. There are three kinds of functional group NH2, OH and COOH, in the amastatin molecule.
Functions
It is a competitive inhibitor of the aminopeptidases A and M2. It inhibits cytosolic leucine aminopeptidase, microsomal aminopeptidase M and bacterial leucine aminopeptidase3.
References
1.Tobe H, Morishima H, Aoyagi T, Umezawa H, Isshiki K, Nakamura K, Yoshioka T, Shimauchi Y, Inui T. (!982). Synthesis and structure-activity relationships of amastatin analogues, inhibitors of aminopeptidase A. Agric. Biol. Chem., 46:1865-1872.
2.Rich DH, Moon BJ, Harbeson S (1984). Inhibition of aminopeptidases by amastatin and bestatin derivatives. Effect of inhibitor structure on slow-binding processes. J Med Chem., 27(4):417-22.
3.Wilkes SH, Prescott JM. (1985). The slow, tight binding of bestatin and amastatin to aminopeptidases. J Biol Chem., 260(24):13154-62.
Wednesday, June 3, 2009
Allatostatins
Definition
Allatostatins (ASTs) are pleiotropic neuropeptide hormones in insects and crustacean. There major function in the insect is the inhibition of juvenile hormone synthesis by the corpora allata and reduce their food intake1.
Discovery
The first identified ASTs were isolated from brain-retro cerebral complexes of the cockroach Diploptera punctata2.
Classification
ASTs encompass a group of three families determined by consensus sequences, the cockroach type representing the FGLa family, the cricket type representing the W(X)6 Wa family and the PISCF family1.
Structural Characteristics
AST’s are 8-13 amino acids long, are amidated, and show sequence similarity, including a 3-amino acid sequence at the C-terminal end that is common to all four peptides. The peptide sequences are as follows: allatostatin-1, Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu-NH2; allatostatin-2, Gly-Asp-Gly-Arg-Leu-Tyr-Ala-Phe-Gly-Leu-NH2; allatostatin-3, Gly-Gly-Ser-Leu-Tyr-Ser-Phe-Gly-Leu-NH2; and allatostatin-4, Asp-Arg-Leu-Tyr-Ser-Phe-Gly-Leu-NH23.
Mode of action
In mammalian cells, allatostatin bind to AST receptors to open G-protein coupled inward rectifying potassium channels, resulting in reduced membrane potential and input resistance4.
Function
The action of ASTs have been largely defined in individual species, in the case of the FGLamide family, such actions include (1) the inhibition of vitellogenin production by fat body in cockroaches, (2) the inhibition of myotropic activity, particularly in gut tissue of Dictyoptera and Orthoptera, (3) regulation of release of digestive enzymes in the midgut of cockroaches, (4) neurotransmission in crab stomatogastric ganglion and possibly cockroach CNS.The biological action of the W(x) 6 Wamide family include (1) Inhibition of ectysteroid biosynthesis (prothoracicostatic activity) by prothoracic glands in silk moth and ovaries of crickets, (2) Inhibition of locust oviduct muscle, (3) Inhibition of spontaneous muscle contraction in foregut of the cockroach. The PISCF family display biological effect similar to the two AST families inhibiting contraction in larval drosophila heart muscle. This peptide family plays a role in the regulation of migratory flight in Lepidoptera.
References
1.Stay B and Tobe SS (2007). "The role of allatostatins in juvenile hormone synthesis in insects and crustaceans". Annu. Rev. Entomo., 52: 277–99.
2.Pratt GE, Farnsworth DE, Fok KF, Siegel NR, McCormack AL, Shabanowitz J, Hunt DF, Feyereisen R (1991). Identity of a second type of allatostatin from cockroach brains: an octadecapeptide amide with a tyrosine-rich address sequence. Proc Natl Acad Sci., 88(6): 2412–2416.
3.Woodhead AP, Stay B, Seidel SL, Khan MA, Tobe SS (1989). Primary structure of four allatostatins: neuropeptide inhibitors of juvenile hormone synthesis. Proc Natl Acad Sci., 86(15):5997-6001.
4.Tan EM, Yamaguchi Y, Horwitz GD, Gosgnach S, Lein ES, Goulding M, Albright TD, Callaway EM (2006). Selective and quickly reversible inactivation of mammalian neurons in vivo uses the Drosophila allatostatin receptor. Neuron, 1:57–170.
Allatostatins (ASTs) are pleiotropic neuropeptide hormones in insects and crustacean. There major function in the insect is the inhibition of juvenile hormone synthesis by the corpora allata and reduce their food intake1.
Discovery
The first identified ASTs were isolated from brain-retro cerebral complexes of the cockroach Diploptera punctata2.
Classification
ASTs encompass a group of three families determined by consensus sequences, the cockroach type representing the FGLa family, the cricket type representing the W(X)6 Wa family and the PISCF family1.
Structural Characteristics
AST’s are 8-13 amino acids long, are amidated, and show sequence similarity, including a 3-amino acid sequence at the C-terminal end that is common to all four peptides. The peptide sequences are as follows: allatostatin-1, Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu-NH2; allatostatin-2, Gly-Asp-Gly-Arg-Leu-Tyr-Ala-Phe-Gly-Leu-NH2; allatostatin-3, Gly-Gly-Ser-Leu-Tyr-Ser-Phe-Gly-Leu-NH2; and allatostatin-4, Asp-Arg-Leu-Tyr-Ser-Phe-Gly-Leu-NH23.
Mode of action
In mammalian cells, allatostatin bind to AST receptors to open G-protein coupled inward rectifying potassium channels, resulting in reduced membrane potential and input resistance4.
Function
The action of ASTs have been largely defined in individual species, in the case of the FGLamide family, such actions include (1) the inhibition of vitellogenin production by fat body in cockroaches, (2) the inhibition of myotropic activity, particularly in gut tissue of Dictyoptera and Orthoptera, (3) regulation of release of digestive enzymes in the midgut of cockroaches, (4) neurotransmission in crab stomatogastric ganglion and possibly cockroach CNS.The biological action of the W(x) 6 Wamide family include (1) Inhibition of ectysteroid biosynthesis (prothoracicostatic activity) by prothoracic glands in silk moth and ovaries of crickets, (2) Inhibition of locust oviduct muscle, (3) Inhibition of spontaneous muscle contraction in foregut of the cockroach. The PISCF family display biological effect similar to the two AST families inhibiting contraction in larval drosophila heart muscle. This peptide family plays a role in the regulation of migratory flight in Lepidoptera.
References
1.Stay B and Tobe SS (2007). "The role of allatostatins in juvenile hormone synthesis in insects and crustaceans". Annu. Rev. Entomo., 52: 277–99.
2.Pratt GE, Farnsworth DE, Fok KF, Siegel NR, McCormack AL, Shabanowitz J, Hunt DF, Feyereisen R (1991). Identity of a second type of allatostatin from cockroach brains: an octadecapeptide amide with a tyrosine-rich address sequence. Proc Natl Acad Sci., 88(6): 2412–2416.
3.Woodhead AP, Stay B, Seidel SL, Khan MA, Tobe SS (1989). Primary structure of four allatostatins: neuropeptide inhibitors of juvenile hormone synthesis. Proc Natl Acad Sci., 86(15):5997-6001.
4.Tan EM, Yamaguchi Y, Horwitz GD, Gosgnach S, Lein ES, Goulding M, Albright TD, Callaway EM (2006). Selective and quickly reversible inactivation of mammalian neurons in vivo uses the Drosophila allatostatin receptor. Neuron, 1:57–170.
Agouti Related Peptides
Definition
Agouti-related peptide (AgRP) is a neuropeptide produced in the brain in the arcuate nucleus of the hypothalamus. It is an endogenous antagonist of melanocortin receptors (MC3-R and MC4-R) which plays a critical role in energy balance.
Discovery
It was identified independently by two teams based on sequence similarity with Agouti signalling peptide, a protein synthesized in the skin that controls coat color1,2.
Classification
There are 3 synthetic AgRP fragments in humans, viz AgRP (25-51), AgRP (54-82) and AgRP (83-132). Amino-terminal fragments AgRP (25-51) and (54-82) were devoid of significant antagonist activity, whereas the amidated carboxyl-terminal AGRP fragment (83-132)-NH2 is potently active3.
Structural characteristics
The human AgRP is 132 amino acids in length, and is about 25 percent identical to agouti polypeptide. It contains 11 cysteines, the majority of which are located at the carboxyl terminal end of the polypeptide, and form 5 disulfide bridges4. The C-terminal portion of the peptide (87-132) is believed to be necessary for optimal binding and contains a five fingered spider-toxin motif with an eight amino acid portion mimicking alpha -MSH.
Mode of action
AgRP binds specifically to MC3-R and MC4-R as an inverse agonist. This inverse agonism antagonizes the action of alpha-MSH and also brings down the level of cAMP (secondary messanger) produced in the affected cells.
Functions
The major function of AgRP is to increase appetite and decrease metabolism. It is one of the most potent and longest appetite stimulator. It can used in treatment of obesity and is particularly beneficial in the prevention and treatment of type 2 diabetes5.
References
1.Shutter JR, Graham M, Kinsey AC, Scully S, Lüthy R, Stark KL (March 1997). "Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice". Genes & Development 11 (5): 593–602.
2.Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS (October 1997). "Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein". Science (New York, N.Y.) 278 (5335): 135–8.
3.Quillan JM, Sadée W, Wei ET, Jimenez C, Ji L, Chang JK (1998). A synthetic human Agouti-related protein-(83-132)-NH2 fragment is a potent inhibitor of melanocortin receptor function. FEBS Lett, 428(1-2):59-62.
4.Bures EJ, Hui JO, Young Y, Chow DT, Katta V, Rohde MF, Zeni L, Rosenfeld RD, Stark KL, Haniu M (1998). Determination of disulfide structure in agouti-related protein (AGRP) by stepwise reduction and alkylation. Biochemistry, 37(35):12172-12177.
5.Wilding JP (2002). Neuropeptides and appetite control. Diabet Med, 19(8):619-627
Agouti-related peptide (AgRP) is a neuropeptide produced in the brain in the arcuate nucleus of the hypothalamus. It is an endogenous antagonist of melanocortin receptors (MC3-R and MC4-R) which plays a critical role in energy balance.
Discovery
It was identified independently by two teams based on sequence similarity with Agouti signalling peptide, a protein synthesized in the skin that controls coat color1,2.
Classification
There are 3 synthetic AgRP fragments in humans, viz AgRP (25-51), AgRP (54-82) and AgRP (83-132). Amino-terminal fragments AgRP (25-51) and (54-82) were devoid of significant antagonist activity, whereas the amidated carboxyl-terminal AGRP fragment (83-132)-NH2 is potently active3.
Structural characteristics
The human AgRP is 132 amino acids in length, and is about 25 percent identical to agouti polypeptide. It contains 11 cysteines, the majority of which are located at the carboxyl terminal end of the polypeptide, and form 5 disulfide bridges4. The C-terminal portion of the peptide (87-132) is believed to be necessary for optimal binding and contains a five fingered spider-toxin motif with an eight amino acid portion mimicking alpha -MSH.
Mode of action
AgRP binds specifically to MC3-R and MC4-R as an inverse agonist. This inverse agonism antagonizes the action of alpha-MSH and also brings down the level of cAMP (secondary messanger) produced in the affected cells.
Functions
The major function of AgRP is to increase appetite and decrease metabolism. It is one of the most potent and longest appetite stimulator. It can used in treatment of obesity and is particularly beneficial in the prevention and treatment of type 2 diabetes5.
References
1.Shutter JR, Graham M, Kinsey AC, Scully S, Lüthy R, Stark KL (March 1997). "Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice". Genes & Development 11 (5): 593–602.
2.Ollmann MM, Wilson BD, Yang YK, Kerns JA, Chen Y, Gantz I, Barsh GS (October 1997). "Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein". Science (New York, N.Y.) 278 (5335): 135–8.
3.Quillan JM, Sadée W, Wei ET, Jimenez C, Ji L, Chang JK (1998). A synthetic human Agouti-related protein-(83-132)-NH2 fragment is a potent inhibitor of melanocortin receptor function. FEBS Lett, 428(1-2):59-62.
4.Bures EJ, Hui JO, Young Y, Chow DT, Katta V, Rohde MF, Zeni L, Rosenfeld RD, Stark KL, Haniu M (1998). Determination of disulfide structure in agouti-related protein (AGRP) by stepwise reduction and alkylation. Biochemistry, 37(35):12172-12177.
5.Wilding JP (2002). Neuropeptides and appetite control. Diabet Med, 19(8):619-627
Monday, June 1, 2009
ACTH and Related Peptide Sequences
Definition
Adrenocorticotropic hormone (ACTH) or corticotropin is a hormone produced by the anterior pituitary gland that stimulates the adrenal cortex.
Related peptides
The six related peptides include smaller biologically active fragments (hormones) which are derived from a common precursor by differential processing of the pro-opiomelanocortin polyprotein (POMC) viz. ACTH, corticotrophin like intermediate lobe protein [CLIP], ß-endorphin, gamma-lipotropin [yLPH], met-encephalin and alpha-melanotropin [aMSH]1.
Discovery
The properties of ACTH were first investigated in the 1930s. In 1933, research groups headed by James Collip, Herbert Evans and Bemardo Houssay used pituitary extracts to stimulate the adrenal cortex. American biochemist Choh Hao Li was one of several scientists who isolated ACTH in 1943 and synthesized it in 1963.
Structural characteristics
ACTH has a molecular weight of 4541.3 K Da2. It is a straight-chain peptide molecule consisting of 39 amino. The first 24 and last 7 amino acids are identical and there are minor differences in amino acids 25 through 32. Only the first 20 amino acids are required for full activity, referred as active centre.
Mechanism of action
ACTH enters the systemic circulation and binds to specific high affinity receptors located on the surface of adrenal cortical cells and the skin. ACTH receptor is a seven membrane-spanning G-protein coupled receptor3, which upon ligand binding undergoes conformation changes that stimulate the enzyme adenylate cyclase, which leads to an increase in intracellular cAMP and subsequent activation of protein kinase A. The activation of protein kinase A ultimately results in stimulation of steroidogenesis.
Function
ACTH's principal function is to stimulate the cortex of the adrenal glands to secrete a group of steroid hormones called glucocorticoids, mineralocorticoids and androgens steroids. Glucocorticoid hormones control the body's use of sugar and also help regulate biological functions during stressful moments. It stimulates the conversion of cholesterol into pregnenolone, the precursor of all steroid hormones. It is used in the treatment of rheumatoid arthritis, ulcerative colitis, hepatitis and to relieve pain. They play a major role in memory processing, by facilitating essential protein synthesis at sites specific for the memory4.
References
1. Funkelstein L, Toneff T, Mosier C, Hwang SR, Beuschlein F, Lichtenauer UD, Reinheckel T, Peters C, Hook V (2008). Major role of cathepsin L for producing the peptide hormones ACTH, beta-endorphin, and alpha-MSH, illustrated by protease gene knockout and expression. J Biol Chem., 283(51):35652-35659.
2.Lee TH, Lerner AB, Buettner-Janusch V (1961). On the structure of human corticotropin (adrenocorticotropic hormone). J. Biol. Chem., 236:2970-2974.
3.Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992). The cloning of a family of genes that encode the melanocortin receptors. Science, 257:248–1251
4.Flood JF, Jarvik ME, Bennett EL, Orme AE (1976). Effects of ACTH peptide fragments on memory formation. Pharmacol Biochem Behav., 5:41-51.
Adrenocorticotropic hormone (ACTH) or corticotropin is a hormone produced by the anterior pituitary gland that stimulates the adrenal cortex.
Related peptides
The six related peptides include smaller biologically active fragments (hormones) which are derived from a common precursor by differential processing of the pro-opiomelanocortin polyprotein (POMC) viz. ACTH, corticotrophin like intermediate lobe protein [CLIP], ß-endorphin, gamma-lipotropin [yLPH], met-encephalin and alpha-melanotropin [aMSH]1.
Discovery
The properties of ACTH were first investigated in the 1930s. In 1933, research groups headed by James Collip, Herbert Evans and Bemardo Houssay used pituitary extracts to stimulate the adrenal cortex. American biochemist Choh Hao Li was one of several scientists who isolated ACTH in 1943 and synthesized it in 1963.
Structural characteristics
ACTH has a molecular weight of 4541.3 K Da2. It is a straight-chain peptide molecule consisting of 39 amino. The first 24 and last 7 amino acids are identical and there are minor differences in amino acids 25 through 32. Only the first 20 amino acids are required for full activity, referred as active centre.
Mechanism of action
ACTH enters the systemic circulation and binds to specific high affinity receptors located on the surface of adrenal cortical cells and the skin. ACTH receptor is a seven membrane-spanning G-protein coupled receptor3, which upon ligand binding undergoes conformation changes that stimulate the enzyme adenylate cyclase, which leads to an increase in intracellular cAMP and subsequent activation of protein kinase A. The activation of protein kinase A ultimately results in stimulation of steroidogenesis.
Function
ACTH's principal function is to stimulate the cortex of the adrenal glands to secrete a group of steroid hormones called glucocorticoids, mineralocorticoids and androgens steroids. Glucocorticoid hormones control the body's use of sugar and also help regulate biological functions during stressful moments. It stimulates the conversion of cholesterol into pregnenolone, the precursor of all steroid hormones. It is used in the treatment of rheumatoid arthritis, ulcerative colitis, hepatitis and to relieve pain. They play a major role in memory processing, by facilitating essential protein synthesis at sites specific for the memory4.
References
1. Funkelstein L, Toneff T, Mosier C, Hwang SR, Beuschlein F, Lichtenauer UD, Reinheckel T, Peters C, Hook V (2008). Major role of cathepsin L for producing the peptide hormones ACTH, beta-endorphin, and alpha-MSH, illustrated by protease gene knockout and expression. J Biol Chem., 283(51):35652-35659.
2.Lee TH, Lerner AB, Buettner-Janusch V (1961). On the structure of human corticotropin (adrenocorticotropic hormone). J. Biol. Chem., 236:2970-2974.
3.Mountjoy KG, Robbins LS, Mortrud MT, Cone RD (1992). The cloning of a family of genes that encode the melanocortin receptors. Science, 257:248–1251
4.Flood JF, Jarvik ME, Bennett EL, Orme AE (1976). Effects of ACTH peptide fragments on memory formation. Pharmacol Biochem Behav., 5:41-51.
Atrial Natriuretic Peptides (ANP/ANF) and Related Peptides
Definition
Atrial natriuretic peptide (ANP), atrial natriuretic factor (ANF), or atriopeptin, is a hormone secreted by heart muscle cells. It is involved in the homeostatic control of body water, sodium, potassium and fat. It is released by muscle cells in the upper chambers (atria) of the heart (atrial myocytes), in response to high blood pressure. It is closely related to brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP).
Discovery
ANP was discovered in 1981 by a team in Ottawa led by Adolfo J. de Bold after they made the seminal observation that injection of atrial tissue extracts into rats caused copious natriuresis1.
Structural characteristics
ANP is a 28-amino acid peptide with a 17-amino acid ring in the middle of the molecule. The ring is formed by a disulfide bond between two cysteine residues at positions 7 and 23. BNP and CNP also share the same amino acid ring. The ANP receptor occurs as a dimer of a single span transmembrane polypeptide, each containing an extracellular hormone-binding domain and an intracellular domain consisting of a protein kinase-like, ATP-dependent regulatory domain and a GC catalytic domain2.
Mode of action
The activities of ANP are mediated by the ANP receptor or the A-type natriuretic peptide receptor carrying intrinsic guanylate cyclase (GC) catalytic activity. Binding of the hormone to the receptor stimulates GC catalytic activity, thereby elevating intracellular cGMP levels. cGMP in turn, mediates the hormonal actions through cGMP-regulated ion channels, protein kinases and phosphodiesterases.
Functions
ANP stimulates vasodilatation, fluid egress, increases glomerular filtration and salt and water excretion. It also blocks the release and actions of several hormones, including angiotensin II, aldosterone and vasopressin. ANP levels are commonly elevated when there is excessive fluid volume or hypertension, and the hormone may be important in combating these states. It shows promise as an agent to treat heart failure, renal failure and fluid excess states3.
References
1.Mebazaa A and Payen D (1990). Atrial natriuretic factor. Ann Fr Anesth Reanim., 9(2):153-168.
2.Ogawa H, Qiu Y, Ogata CM, Misono KS (2004). Crystal structure of hormone-bound atrial natriuretic peptide receptor extracellular domain: rotation mechanism for transmembrane signal transduction. J Biol Chem., 279(27):28625-28631.
3.Baxter JD, Lewicki JA, Gardner DG (1988). Atrial Natriuretic Peptide. Nature BioTechnology, 6: 529 – 546.
Atrial natriuretic peptide (ANP), atrial natriuretic factor (ANF), or atriopeptin, is a hormone secreted by heart muscle cells. It is involved in the homeostatic control of body water, sodium, potassium and fat. It is released by muscle cells in the upper chambers (atria) of the heart (atrial myocytes), in response to high blood pressure. It is closely related to brain natriuretic peptide (BNP) and C-type natriuretic peptide (CNP).
Discovery
ANP was discovered in 1981 by a team in Ottawa led by Adolfo J. de Bold after they made the seminal observation that injection of atrial tissue extracts into rats caused copious natriuresis1.
Structural characteristics
ANP is a 28-amino acid peptide with a 17-amino acid ring in the middle of the molecule. The ring is formed by a disulfide bond between two cysteine residues at positions 7 and 23. BNP and CNP also share the same amino acid ring. The ANP receptor occurs as a dimer of a single span transmembrane polypeptide, each containing an extracellular hormone-binding domain and an intracellular domain consisting of a protein kinase-like, ATP-dependent regulatory domain and a GC catalytic domain2.
Mode of action
The activities of ANP are mediated by the ANP receptor or the A-type natriuretic peptide receptor carrying intrinsic guanylate cyclase (GC) catalytic activity. Binding of the hormone to the receptor stimulates GC catalytic activity, thereby elevating intracellular cGMP levels. cGMP in turn, mediates the hormonal actions through cGMP-regulated ion channels, protein kinases and phosphodiesterases.
Functions
ANP stimulates vasodilatation, fluid egress, increases glomerular filtration and salt and water excretion. It also blocks the release and actions of several hormones, including angiotensin II, aldosterone and vasopressin. ANP levels are commonly elevated when there is excessive fluid volume or hypertension, and the hormone may be important in combating these states. It shows promise as an agent to treat heart failure, renal failure and fluid excess states3.
References
1.Mebazaa A and Payen D (1990). Atrial natriuretic factor. Ann Fr Anesth Reanim., 9(2):153-168.
2.Ogawa H, Qiu Y, Ogata CM, Misono KS (2004). Crystal structure of hormone-bound atrial natriuretic peptide receptor extracellular domain: rotation mechanism for transmembrane signal transduction. J Biol Chem., 279(27):28625-28631.
3.Baxter JD, Lewicki JA, Gardner DG (1988). Atrial Natriuretic Peptide. Nature BioTechnology, 6: 529 – 546.
Saturday, May 30, 2009
AKT/PKB/Rac-protein kinases
Definition
Protein kinase B (PKB), also known as Akt (PKB/Akt), is a serine/threonine phosphoryl transferase and a downstream effector of the phosphoinositol–3 kinase (PI3K) signaling.
Discovery
The AKT protein kinase (also referred to as protein kinase B or Rac-protein kinase) was initially identified as an acute transforming component of the AKT8 virus isolated from a murine T cell lymphoma1, 2.
Classification
PKB/Akt belongs to the AGC subfamily of the protein kinase superfamily, which consists of 518 members in humans and is conserved from primitive metazoans to humans3.
Structural characteristics
The PKB subfamily comprises three mammalian isoforms, PKB , PKBß and PKB (Akt1, Akt2 and Akt3, respectively), which are products of distinct genes and share a conserved structure that includes three functional domains: an N-terminal pleckstrin homology (PH) domain, a central kinase domain, and a C-terminal regulatory domain containing the hydrophobic motif (HM) phosphorylation site [FxxF(S/T)Y]4.
Mechanism of action
As PKB is a downstream component of (PI3K) signaling, that is activated upon (1) autophosphorylation of receptor tyrosine kinases induced by ligands (such as insulin or other growth factors), (2) stimulation of G-protein-coupled receptors, or (3) activation of integrin signaling5, 6.
Functions
PKB/Akt plays an important role in all the cellular processes such as cell migration, survival, differentiation, as well as apoptosis7. Moreover, upregulation of Akt activity is recognized in variety of neoplasms, as well as chemoresistance8. To understand the role of PKB, tremendous efforts have been made to identify its physiological substrates. Most of the PKB substrates contain the minimal consensus sequence RxRxx(S/T), where x is any amino acid and S/T is the phosphorylation site. A genome–wide screen using this sequence motif will list more than 1,000 putative Akt phosphorylation targets in humans. Degenerate peptide library approach has also been used for screening various substrates for PKB/Akt9.
Reference:
1. Staal SP (1987). Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci, 84(14):5034-5037.
2. Staal SP, Hartley JW (1988). Thymic lymphoma induction by the AKT8 murine retrovirus. J Exp Med, 167(3):1259-64.
3. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC (2002). Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell, 10(1):151-62.
4. Hanada M, Feng J, Hemmings BA (2004). Structure, regulation and function of PKB/AKT--a major therapeutic target. Biochim Biophys Acta, 1697(1-2):3-16.
5. Foster, F. M., Traer, C. J., Abraham, S. M. and Fry, M. J. (2003). The phosphoinositide (PI) 3-kinase family. J. Cell Sci., 116, 3037-3040.
6. Wymann, M. P., Zvelebil, M. and Laffargue, M.(2003). Phosphoinositide 3-kinase signalling–which way to target? Trends Pharmacol. Sci., 24, 366-376.
7. Song G, Ouyang G, Bao S (2005). The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med, 9(1):59-71
8. Kim D, Dan HC, Park S, Yang L, Liu Q, Kaneko S, Ning J, He L, Yang H, Sun M, Nicosia SV, Cheng JQ (2005). AKT/PKB signaling mechanisms in cancer and chemoresistance. Front Biosci., 10:975-87.
9. Obata T, Yaffe MB, Leparc GG, Piro ET, Maegawa H, Kashiwagi A, Kikkawa R, Cantley LC (2000). Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J Biol Chem, 275(46):36108-36115.
Protein kinase B (PKB), also known as Akt (PKB/Akt), is a serine/threonine phosphoryl transferase and a downstream effector of the phosphoinositol–3 kinase (PI3K) signaling.
Discovery
The AKT protein kinase (also referred to as protein kinase B or Rac-protein kinase) was initially identified as an acute transforming component of the AKT8 virus isolated from a murine T cell lymphoma1, 2.
Classification
PKB/Akt belongs to the AGC subfamily of the protein kinase superfamily, which consists of 518 members in humans and is conserved from primitive metazoans to humans3.
Structural characteristics
The PKB subfamily comprises three mammalian isoforms, PKB , PKBß and PKB (Akt1, Akt2 and Akt3, respectively), which are products of distinct genes and share a conserved structure that includes three functional domains: an N-terminal pleckstrin homology (PH) domain, a central kinase domain, and a C-terminal regulatory domain containing the hydrophobic motif (HM) phosphorylation site [FxxF(S/T)Y]4.
Mechanism of action
As PKB is a downstream component of (PI3K) signaling, that is activated upon (1) autophosphorylation of receptor tyrosine kinases induced by ligands (such as insulin or other growth factors), (2) stimulation of G-protein-coupled receptors, or (3) activation of integrin signaling5, 6.
Functions
PKB/Akt plays an important role in all the cellular processes such as cell migration, survival, differentiation, as well as apoptosis7. Moreover, upregulation of Akt activity is recognized in variety of neoplasms, as well as chemoresistance8. To understand the role of PKB, tremendous efforts have been made to identify its physiological substrates. Most of the PKB substrates contain the minimal consensus sequence RxRxx(S/T), where x is any amino acid and S/T is the phosphorylation site. A genome–wide screen using this sequence motif will list more than 1,000 putative Akt phosphorylation targets in humans. Degenerate peptide library approach has also been used for screening various substrates for PKB/Akt9.
Reference:
1. Staal SP (1987). Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci, 84(14):5034-5037.
2. Staal SP, Hartley JW (1988). Thymic lymphoma induction by the AKT8 murine retrovirus. J Exp Med, 167(3):1259-64.
3. Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC (2002). Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. Mol Cell, 10(1):151-62.
4. Hanada M, Feng J, Hemmings BA (2004). Structure, regulation and function of PKB/AKT--a major therapeutic target. Biochim Biophys Acta, 1697(1-2):3-16.
5. Foster, F. M., Traer, C. J., Abraham, S. M. and Fry, M. J. (2003). The phosphoinositide (PI) 3-kinase family. J. Cell Sci., 116, 3037-3040.
6. Wymann, M. P., Zvelebil, M. and Laffargue, M.(2003). Phosphoinositide 3-kinase signalling–which way to target? Trends Pharmacol. Sci., 24, 366-376.
7. Song G, Ouyang G, Bao S (2005). The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med, 9(1):59-71
8. Kim D, Dan HC, Park S, Yang L, Liu Q, Kaneko S, Ning J, He L, Yang H, Sun M, Nicosia SV, Cheng JQ (2005). AKT/PKB signaling mechanisms in cancer and chemoresistance. Front Biosci., 10:975-87.
9. Obata T, Yaffe MB, Leparc GG, Piro ET, Maegawa H, Kashiwagi A, Kikkawa R, Cantley LC (2000). Peptide and protein library screening defines optimal substrate motifs for AKT/PKB. J Biol Chem, 275(46):36108-36115.
Alloferons
Definition
Alloferons also known as immunomodulating peptides are slightly cationic and non-toxic antiviral peptides that are isolated from the blood of an insect. Alloferons have no teratogenic, embryotoxic or mutagenic properties.
Discovery
Alloferons were first isolated from bacteria-challenged larvae of an experimentally infected blow fly, Calliphora vicina (Diptera) 1. This species, along with other surgical maggots, has a long history of medical use in wound and ulcer healing
Classification
Alloferons are members of cytokine-like peptide family of the insect immune system. They are naturally occurring peptides, usually consisting of 12-13 amino acids. Twenty types of alloferons are found in nature and are classified as as alloferon 1 to alloferon 20. Alloferons 1 and 2 are natural peptides, alloferons 3 and 4 are truncated forms of alloferon 1. Alloferons 5-20 are modifications of variable fragments of the basic structure of alloferon2.
Structural characteristics
Alloferons are linear, nonglycosylated oligopeptide having a unique amino acid sequence of molecular mass of about 1265 Da. Amino acid sequences of alloferons are homologous to influenza B virus precursor protein.
Mechanism of action
Alloferons mediate signalling by NF-?B pathway to boost recognition of viral and tumor antigens3. They are known to induce the production of endogenic interferons that promote a cascade of defense responses and also enhance CD25 receptor expression. Cytotoxic lymphocytes are stimulated by alloferons upon recognition of nonself or aberrant cells that are subsequently lysed.
Function
Alloferons are useful in the treatment or prophylaxis of various infectious or oncological diseases where improvement of innate immunity, including interferon system and natural cell mediated cytotoxicity can have therapeutic significance4. Alloferons is used as antiviral agent in the treatment of infections caused by influenza virus, herpes virus, papillomatosis, viral hepatitis, AIDS and AIDS relevant secondary infections. They are known also known to have antitumour property, used in the treatment of oncological conditions like acute and chronic leukemia.
References
1. Chernysh S, Kim SI, Bekker G, Pleskach VA, Filatova NA, Anikin VB, Platonov VG, Bulet P (2002). Antiviral and antitumor peptides from insects. Proceedings of the National Academy of Sciences, 99(20):12628-12632.
2. Kim SI, Chernysh S, Bekker G, Makhaldiani NB, Hoffman J, Bulet P (2008). Alloferons—immunomodulatory peptides. Free patents online, 7462360.
3. Ryu MJ, Anikin V, Hong SH, Jeon H, Yu YG, Yu MH, Chernysh S, Lee C (2008). Activation of NF-kappaB by alloferon through down-regulation of antioxidant proteins and IkappaBalpha. Mol Cell Biochem, vol 313(1-2):91-102.
4. Chernysh S (2006). Antitumoral and antiviral peptides. European patent publication, EP 1 705 182 A1.
Alloferons also known as immunomodulating peptides are slightly cationic and non-toxic antiviral peptides that are isolated from the blood of an insect. Alloferons have no teratogenic, embryotoxic or mutagenic properties.
Discovery
Alloferons were first isolated from bacteria-challenged larvae of an experimentally infected blow fly, Calliphora vicina (Diptera) 1. This species, along with other surgical maggots, has a long history of medical use in wound and ulcer healing
Classification
Alloferons are members of cytokine-like peptide family of the insect immune system. They are naturally occurring peptides, usually consisting of 12-13 amino acids. Twenty types of alloferons are found in nature and are classified as as alloferon 1 to alloferon 20. Alloferons 1 and 2 are natural peptides, alloferons 3 and 4 are truncated forms of alloferon 1. Alloferons 5-20 are modifications of variable fragments of the basic structure of alloferon2.
Structural characteristics
Alloferons are linear, nonglycosylated oligopeptide having a unique amino acid sequence of molecular mass of about 1265 Da. Amino acid sequences of alloferons are homologous to influenza B virus precursor protein.
Mechanism of action
Alloferons mediate signalling by NF-?B pathway to boost recognition of viral and tumor antigens3. They are known to induce the production of endogenic interferons that promote a cascade of defense responses and also enhance CD25 receptor expression. Cytotoxic lymphocytes are stimulated by alloferons upon recognition of nonself or aberrant cells that are subsequently lysed.
Function
Alloferons are useful in the treatment or prophylaxis of various infectious or oncological diseases where improvement of innate immunity, including interferon system and natural cell mediated cytotoxicity can have therapeutic significance4. Alloferons is used as antiviral agent in the treatment of infections caused by influenza virus, herpes virus, papillomatosis, viral hepatitis, AIDS and AIDS relevant secondary infections. They are known also known to have antitumour property, used in the treatment of oncological conditions like acute and chronic leukemia.
References
1. Chernysh S, Kim SI, Bekker G, Pleskach VA, Filatova NA, Anikin VB, Platonov VG, Bulet P (2002). Antiviral and antitumor peptides from insects. Proceedings of the National Academy of Sciences, 99(20):12628-12632.
2. Kim SI, Chernysh S, Bekker G, Makhaldiani NB, Hoffman J, Bulet P (2008). Alloferons—immunomodulatory peptides. Free patents online, 7462360.
3. Ryu MJ, Anikin V, Hong SH, Jeon H, Yu YG, Yu MH, Chernysh S, Lee C (2008). Activation of NF-kappaB by alloferon through down-regulation of antioxidant proteins and IkappaBalpha. Mol Cell Biochem, vol 313(1-2):91-102.
4. Chernysh S (2006). Antitumoral and antiviral peptides. European patent publication, EP 1 705 182 A1.
Amyloid b/A4 Protein Precursor (APP) Fragments
Definition
Amyloid precursor protein (APP) is a single transmembrane protein that undergoes sequential proteolysis to generate multiple peptides, including the amyloid beta peptide the major component of the senile plaques that are diagnostic hallmarks of Alzheimer disease (AD).
Discovery
In 1984, Glenner and Wong purified APP derived from the twisted beta-pleated sheet fibrils present in cerebrovascular amyloidoses and in the amyloid plaques associated with Alzheimer disease1.
Structural characteristics
APP is a 110-130 kDa, transmembrane cell surface glycoprotein, which contains N and O, linked sugars. The largest region of the molecule is the extracellular domain. This domain contains a cysteine-rich region of about 200 amino acids and is at the N-terminus of the protein. It has a single membrane-spanning domain towards the carboxyl terminus and a short cytoplasmic tail. APP contains a domain very similar to the Kunitz family of serine protease inhibitors and the APP protein is homologous to protein protease nexin-II2.
Mode of action
APP plays an essential role in the reduction of copper II to copper I. This electron transfer reaction is involved in the formation of reactive oxygen species (e.g., superoxide radical and hydroxyl radical)3 which are extremely reactive with many different cellular components. These reactions can produce large amounts of damage and ultimately results in cell death.
Function
APP plays major roles in the regulation of several important cellular functions, especially in the nervous system, where it is involved in synaptogenesis and synaptic plasticity. The secreted extracellular domain of APP, sAPPa, acts as a growth factor for many types of cells and promotes neuritogenesis in post-mitotic neurons4.
Reference:
1. Furuya H, Sasaki H, Goto I, Wong CW, Glenner GG, Sakaki Y. (1988). Amyloid beta-protein gene duplication is not common in Alzheimer's disease: analysis by polymorphic restriction fragments. Biochem Biophys Res Commun., 150 (1):75-81.
2. Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F (1988). A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature, 331 (6156):525-527.
3. Camakaris J, Voskoboinik I, Mercer JF (1999). Molecular mechanisms of copper homeostasis. Biochem Biophys Res Commun, 261:225-232.
4. Gralle M, Ferreira ST (2007). Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Prog Neurobiol, 82 (1):11-32.
Amyloid precursor protein (APP) is a single transmembrane protein that undergoes sequential proteolysis to generate multiple peptides, including the amyloid beta peptide the major component of the senile plaques that are diagnostic hallmarks of Alzheimer disease (AD).
Discovery
In 1984, Glenner and Wong purified APP derived from the twisted beta-pleated sheet fibrils present in cerebrovascular amyloidoses and in the amyloid plaques associated with Alzheimer disease1.
Structural characteristics
APP is a 110-130 kDa, transmembrane cell surface glycoprotein, which contains N and O, linked sugars. The largest region of the molecule is the extracellular domain. This domain contains a cysteine-rich region of about 200 amino acids and is at the N-terminus of the protein. It has a single membrane-spanning domain towards the carboxyl terminus and a short cytoplasmic tail. APP contains a domain very similar to the Kunitz family of serine protease inhibitors and the APP protein is homologous to protein protease nexin-II2.
Mode of action
APP plays an essential role in the reduction of copper II to copper I. This electron transfer reaction is involved in the formation of reactive oxygen species (e.g., superoxide radical and hydroxyl radical)3 which are extremely reactive with many different cellular components. These reactions can produce large amounts of damage and ultimately results in cell death.
Function
APP plays major roles in the regulation of several important cellular functions, especially in the nervous system, where it is involved in synaptogenesis and synaptic plasticity. The secreted extracellular domain of APP, sAPPa, acts as a growth factor for many types of cells and promotes neuritogenesis in post-mitotic neurons4.
Reference:
1. Furuya H, Sasaki H, Goto I, Wong CW, Glenner GG, Sakaki Y. (1988). Amyloid beta-protein gene duplication is not common in Alzheimer's disease: analysis by polymorphic restriction fragments. Biochem Biophys Res Commun., 150 (1):75-81.
2. Ponte P, Gonzalez-DeWhitt P, Schilling J, Miller J, Hsu D, Greenberg B, Davis K, Wallace W, Lieberburg I, Fuller F (1988). A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature, 331 (6156):525-527.
3. Camakaris J, Voskoboinik I, Mercer JF (1999). Molecular mechanisms of copper homeostasis. Biochem Biophys Res Commun, 261:225-232.
4. Gralle M, Ferreira ST (2007). Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Prog Neurobiol, 82 (1):11-32.
Amylin Peptides and Fragments
Definition
Amylin or Islet amyloid polypeptide (IAPP), a 37-amino acid peptide is secreted by beta-islet cells of the pancreas and a major component of the amyloid deposits in persons with type 2 diabetes mellitus. Amylin may be referred to as insulin’s “fraternal twin” as it is constitutively expressed with insulin in response to elevations of plasma glucose.
Discovery
The knowledge of occurrence of amyloid deposits in islets of Langerhans, major pathologic feature of diabetics has been known for a century. But, the discovery of amylin as a major component of amyloid deposits was by two independent groups in 19871, 2.
Structural characteristics
The human amylin has an amino acid sequence KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY, with a disulfide bridge between cysteine residues 2 and 7. The features, amidated C-terminus and the disulfide bridge are necessary for the full biological activity of amylin3. Amylin amino acid sequence is 46% and 43% identical to those of the calcitonin gene-related neuropeptides CGRP-2 and CGRP-1. The (20-29) fragment of amylin is critical to the pathogenesis of islet amyloid4.
Mechanism of action
Amylin is synthesized, packaged within the golgi apparatus and secreted within the secretory granule by the islet beta cell. They have binding sites within the renal cortex in the area of the juxtaglomerular apparatus and it activates the rennin angiotensin aldosterone system. It also acts upon the circulatory system by inhibiting the secretion of the atrial natriuretic peptide (ANP)5.
Function
Amylin inhibits gastric emptying and is important in controlling and delaying the rate of meal derived glucose. It inhibits hepatic release and production of glucose in the postprandial period. They also have been shown to inhibit glucagon secretion and somatostatin. Amylin causes vasodilatation by dilating the non-striated muscles of the blood vessels. It is also known to increase thirst level which indicates it has an action within the central nervous system6.
References
1. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB (1987). Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci., 84(23):8628-32.
2. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH (1987). Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol, 127(3):414-417.
3. Roberts AN, Leighton B, Todd JA, Cockburn D, Schofield PN, Sutton R, Holt S, Boyd Y, Day AJ, Foot EA, et al,(1989). Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. Proc Natl Acad Sci, 86(24):9662-9666.
4. Guidobono F, Pagani F, Ticozzi C, Sibilia V, Pecile A, Netti C (1997). Protection by amylin of gastric erosions induced by indomethacin or ethanol in rats. Br J Pharmacol, 120(4):581-586.
5. Piao FL, Cao C, Han JH, Kim SZ, Cho KW, Kim SH (2004). Amylin-induced suppression of ANP secretion through receptors for CGRP1 and salmon calcitonin. Regul Pept, 117: 59-166.
6. Hayden MR, Tyagi SC (2002). Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus. Journal of the Pancrease, 3(4): 86-108.
Amylin or Islet amyloid polypeptide (IAPP), a 37-amino acid peptide is secreted by beta-islet cells of the pancreas and a major component of the amyloid deposits in persons with type 2 diabetes mellitus. Amylin may be referred to as insulin’s “fraternal twin” as it is constitutively expressed with insulin in response to elevations of plasma glucose.
Discovery
The knowledge of occurrence of amyloid deposits in islets of Langerhans, major pathologic feature of diabetics has been known for a century. But, the discovery of amylin as a major component of amyloid deposits was by two independent groups in 19871, 2.
Structural characteristics
The human amylin has an amino acid sequence KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY, with a disulfide bridge between cysteine residues 2 and 7. The features, amidated C-terminus and the disulfide bridge are necessary for the full biological activity of amylin3. Amylin amino acid sequence is 46% and 43% identical to those of the calcitonin gene-related neuropeptides CGRP-2 and CGRP-1. The (20-29) fragment of amylin is critical to the pathogenesis of islet amyloid4.
Mechanism of action
Amylin is synthesized, packaged within the golgi apparatus and secreted within the secretory granule by the islet beta cell. They have binding sites within the renal cortex in the area of the juxtaglomerular apparatus and it activates the rennin angiotensin aldosterone system. It also acts upon the circulatory system by inhibiting the secretion of the atrial natriuretic peptide (ANP)5.
Function
Amylin inhibits gastric emptying and is important in controlling and delaying the rate of meal derived glucose. It inhibits hepatic release and production of glucose in the postprandial period. They also have been shown to inhibit glucagon secretion and somatostatin. Amylin causes vasodilatation by dilating the non-striated muscles of the blood vessels. It is also known to increase thirst level which indicates it has an action within the central nervous system6.
References
1. Cooper GJ, Willis AC, Clark A, Turner RC, Sim RB, Reid KB (1987). Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci., 84(23):8628-32.
2. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH (1987). Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. Am J Pathol, 127(3):414-417.
3. Roberts AN, Leighton B, Todd JA, Cockburn D, Schofield PN, Sutton R, Holt S, Boyd Y, Day AJ, Foot EA, et al,(1989). Molecular and functional characterization of amylin, a peptide associated with type 2 diabetes mellitus. Proc Natl Acad Sci, 86(24):9662-9666.
4. Guidobono F, Pagani F, Ticozzi C, Sibilia V, Pecile A, Netti C (1997). Protection by amylin of gastric erosions induced by indomethacin or ethanol in rats. Br J Pharmacol, 120(4):581-586.
5. Piao FL, Cao C, Han JH, Kim SZ, Cho KW, Kim SH (2004). Amylin-induced suppression of ANP secretion through receptors for CGRP1 and salmon calcitonin. Regul Pept, 117: 59-166.
6. Hayden MR, Tyagi SC (2002). Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus. Journal of the Pancrease, 3(4): 86-108.
ADP-Ribosylation Factors (ARF)
Definition
Adenosine diphosphate-ribosylation factor (ARF) proteins are members of the GTP-binding proteins of the Ras superfamily1. They are major regulators of vesicle biogenesis in intracellular traffic, lipid metabolism, microtubule dynamics, development and other cellular processes2.
Discovery
ARF was originally identified as a cofactor for cholera toxin A catalyzed ADP-ribosylation of the stimulatory GTP-binding component of adenylate cyclase3.
Classification
The mammalian ARFs can be grouped into three classes on the basis of their size and sequence identity. ARF1, ARF2 and ARF3 are grouped under class I, ARF4 and ARF5 under class II and ARF6 under class III4.
Structural Characteristics
ARFs contain consensus amino acid sequences involved in GTP binding and hydrolysis which determine their catalytic activity3. They contain two switch regions, which change relative positions between cycles of GDP/GTP-binding. They are similar to heterotrimeric G protein subunits, these peptides are frequently myristoylated in their N-terminal region, which contributes to their membrane association.
Mode of action
The controlled binding and hydrolysis of GTP is critical to ARF function. ARF proteins cycle between GDP-bound, inactive and GTP-bound, active forms, and the cycling is regulated by specific guanine nucleotide releasing factors (GEPs) and GTPase-activating protein (GAPs). GTPase activating proteins (GAPs) hydrolyze bound GTP to GDP, and guanine nucleotide exchange factors adopt a new GTP molecule in place of a bound GDP. The GTP hydrolysis is required in many secretory pathways like formation and docking of vesicles at various membranes. It affects membrane traffic by recruiting coat proteins, including COPI and clathrin adaptor complexes to membranes.
Functions
ARFs function both constitutively within the secretory pathway and as targets of signal transduction in the cell periphery1. ARF proteins function in the regulation of membrane traffic and the organization of the cytoskeleton that are crucial to fundamental cellular processes, such as intracellular sorting/trafficking of newly synthesized proteins and endocytosis/exocytosis. They act at membrane surfaces to modify lipid composition and to recruit coat proteins for the generation of transport vesicles5. ARF proteins play a key regulatory role in the remodeling of actin cytoskeleton necessary for the formation of membrane ruffles and protrusions in association with phospholipase D and members of the Rho GTPase family. These activities of ARF proteins influence the formation, stability and functional integrity of epithelial junctions6.
References
1. Randazzo PA, Nie Z, Miura K, and Hsu VW, (2000). Molecular Aspects of the Cellular Activities of ADP-Ribosylation Factors. Sci. STKE, 2000 (59)
2. Pasqualato S, Renault L, Cherfils J (2002). Arf, Arl, Arp and Sar proteins: a family of GTP-binding proteins with a structural device for 'front-back' communication. EMBO Rep, 3(11):1035-41.
3. Kahn RA and Gilman AG (1984). Purification of a protein cofactor required for ADP-ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera toxin. J. Biol. Chem, 259, 6228-6234.
4. Moss J and Vaughan M (1995). Structure and Function of ARF Proteins: Activators of Cholera Toxin and Critical Components of Intracellular Vesicular Transport Processes. The American Society for Biochemistry and Molecular Biology, 270(21): 12327-12330.
5. Donaldson JG (2008). Arfs and membrane lipids: sensing, generating and responding to membrane curvature. Biochem J, 414(2):189-94.
6. Hiroi T (2009). Regulation of epithelial junctions by proteins of the ADP-ribosylation factor family. Front Biosci., 14:717-730.
Adenosine diphosphate-ribosylation factor (ARF) proteins are members of the GTP-binding proteins of the Ras superfamily1. They are major regulators of vesicle biogenesis in intracellular traffic, lipid metabolism, microtubule dynamics, development and other cellular processes2.
Discovery
ARF was originally identified as a cofactor for cholera toxin A catalyzed ADP-ribosylation of the stimulatory GTP-binding component of adenylate cyclase3.
Classification
The mammalian ARFs can be grouped into three classes on the basis of their size and sequence identity. ARF1, ARF2 and ARF3 are grouped under class I, ARF4 and ARF5 under class II and ARF6 under class III4.
Structural Characteristics
ARFs contain consensus amino acid sequences involved in GTP binding and hydrolysis which determine their catalytic activity3. They contain two switch regions, which change relative positions between cycles of GDP/GTP-binding. They are similar to heterotrimeric G protein subunits, these peptides are frequently myristoylated in their N-terminal region, which contributes to their membrane association.
Mode of action
The controlled binding and hydrolysis of GTP is critical to ARF function. ARF proteins cycle between GDP-bound, inactive and GTP-bound, active forms, and the cycling is regulated by specific guanine nucleotide releasing factors (GEPs) and GTPase-activating protein (GAPs). GTPase activating proteins (GAPs) hydrolyze bound GTP to GDP, and guanine nucleotide exchange factors adopt a new GTP molecule in place of a bound GDP. The GTP hydrolysis is required in many secretory pathways like formation and docking of vesicles at various membranes. It affects membrane traffic by recruiting coat proteins, including COPI and clathrin adaptor complexes to membranes.
Functions
ARFs function both constitutively within the secretory pathway and as targets of signal transduction in the cell periphery1. ARF proteins function in the regulation of membrane traffic and the organization of the cytoskeleton that are crucial to fundamental cellular processes, such as intracellular sorting/trafficking of newly synthesized proteins and endocytosis/exocytosis. They act at membrane surfaces to modify lipid composition and to recruit coat proteins for the generation of transport vesicles5. ARF proteins play a key regulatory role in the remodeling of actin cytoskeleton necessary for the formation of membrane ruffles and protrusions in association with phospholipase D and members of the Rho GTPase family. These activities of ARF proteins influence the formation, stability and functional integrity of epithelial junctions6.
References
1. Randazzo PA, Nie Z, Miura K, and Hsu VW, (2000). Molecular Aspects of the Cellular Activities of ADP-Ribosylation Factors. Sci. STKE, 2000 (59)
2. Pasqualato S, Renault L, Cherfils J (2002). Arf, Arl, Arp and Sar proteins: a family of GTP-binding proteins with a structural device for 'front-back' communication. EMBO Rep, 3(11):1035-41.
3. Kahn RA and Gilman AG (1984). Purification of a protein cofactor required for ADP-ribosylation of the stimulatory regulatory component of adenylate cyclase by cholera toxin. J. Biol. Chem, 259, 6228-6234.
4. Moss J and Vaughan M (1995). Structure and Function of ARF Proteins: Activators of Cholera Toxin and Critical Components of Intracellular Vesicular Transport Processes. The American Society for Biochemistry and Molecular Biology, 270(21): 12327-12330.
5. Donaldson JG (2008). Arfs and membrane lipids: sensing, generating and responding to membrane curvature. Biochem J, 414(2):189-94.
6. Hiroi T (2009). Regulation of epithelial junctions by proteins of the ADP-ribosylation factor family. Front Biosci., 14:717-730.
Subscribe to:
Posts (Atom)